Tech Company Financing Transactions
Factor X Funding Round
On 7/13/2026, Factor X raised financing from private investors.
Transaction Overview
Company Name
Announced On
7/13/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the fresh capital to scale its proprietary nanoparticle architecture, expand its B2B cosmetic ingredient supply networks, and invest in high-throughput tissue-stability testing.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
Undisclosed
Tel Aviv, Undisclosed
Israel
Tel Aviv, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Overview
Factor X has engineered a particle architecture proven to carry RNA intact -- built for the moment it crosses the skin barrier. RNA delivery into cells exists -- in pharma, in gene therapy, in injectable formats. No one has done it topically, at cosmetic grade. That's what Factor X is building.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Eran Orr
Chief Executive Officer
Inbal Gat
Co-Founder
Yaniv Gat
Co-Founder
Shira Orr
Co-Founder
Bar Refaeli
VP - R & D
Ohad Tarcic
Browse more venture capital transactions:
Prev: 7/13/2026: Helsing venture capital transaction
Next: 7/13/2026: Milo Drive venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs